2013 | Aarkstore.com || Insulin Resistance – Pipeline Review, H2 2012

Aarkstore.com announces Latest report -Insulin Resistance – Pipeline Review, H2 2012

ListFree.org (Press Release) - Friday, January 18th, 2013

Aarkstore.com announces, The Latest market research report is available in its vast collection:

Insulin Resistance – Pipeline Review, H2 2012

http://www.aarkstore.com/reports/Insulin-Resistance-–-Pipeline-Review-H2-2012-239254.html

Insulin Resistance – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, Insulin Resistance – Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Insulin Resistance, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Insulin Resistance. Insulin Resistance – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Insulin Resistance.
- A review of the Insulin Resistance products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Insulin Resistance.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.

Table of Contents :

List of Tables 6
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Insulin Resistance Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Insulin Resistance 9
Insulin Resistance Therapeutics under Development by Companies 11
Insulin Resistance Therapeutics under Investigation by Universities/Institutes 12
Late Stage Products 15
Comparative Analysis 15
Mid Clinical Stage Products 16
Comparative Analysis 16
Early Clinical Stage Products 17
Comparative Analysis 17
Discovery and Pre-Clinical Stage Products 18
Comparative Analysis 18
Insulin Resistance Therapeutics – Products under Development by Companies 19
Insulin Resistance Therapeutics – Products under Investigation by Universities/Institutes 20
Companies Involved in Insulin Resistance Therapeutics Development 22
Novartis AG 22

More related reports :

http://www.aarkstore.com/publishers/Global-Markets-Direct-49.html

Hearing Disorders – Pipeline Review, H2 2012

Insulin Resistance – Pipeline Review, H2 2012

Nicotine Addiction – Pipeline Review, H2 2012

Muscular Dystrophy – Pipeline Review, H2 2012

Left Ventricular Dysfunction – Pipeline Review, H2 2012

For More details about above & other Reports plz contact :

Lavanya
Aarkstore.com

Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstore

ListFree.org: Embedded data.

Bookmark and Share Subscribe

 

Contact us at :
Issued By:+918149852585
Email:enquiry@aarkstore.com
Country:houston
WebSite:http://www.aarkstore.com/
Categories:Business
Tags:, , , , , ,

You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.